image source: European Biopharmaceutical Review
8th September 2021
“We Are Losing Our Strongest Allies Against Infectious Diseases” - Dr. Alexander Sturm for European Biopharmaceutical Review (EBR)
To learn more about how antibiotic resistance and antibiotic tolerance are hindering our ability to slow the spread of infectious diseases read an excellent review article in EBR by Dr. Alex Sturm, Senior Scientist at Resistell.
image source: Dr. Martin Oeggerli, Micronaut
25th June 2021
Resistell technology featured in "Die Zeit" magazine
The Resistell's device tests antibiotic resistance faster than ever before. A drop of bacteria is placed on a tip of cantilever sensor which records nano-scale vibrations of living cells. The measurements reveal whether an antibiotic worked or the microbes are still alive.
15th February 2021
Faster to the right antibiotic treatment - Resistell in Schweizerische Ärztezeitung
How do you find the most effective antibiotic for a patient as quickly as possible? The start-up "Resistell" has developed a new type of test for antibiotic resistance. Read more about this test in Schwizerische Ärztezeitung.
11th February 2021
International Day of Women and Girls in Science - European Innovation Council interview with Danuta Cichocka
On the International Day of Women and Girls in Science, European Innovation Council invited Danuta Cichocka, Resistell CEO, the female scientist and entrepreneur, to share her story about her passion in life science in an interview.
10th February 2021
Aus welchem Holz sind Gründerinnen und Gründer geschnitzt?
Die Covid-Pandemie hat alle Bereiche des Lebens erfasst. Auch die Startup- und Gründerszene musste mit der Situation umgehen und unter erschwerten Bedingungen die Projekte weiter führen und antreiben. Gleichzeitig aber hat Corona als Katalysator gewirkt für disruptive Ideen, für Innovation und Unternehmergeist.
7th January 2021
Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.
The Muttenz-based biotech startup proposes an alternative to culture-based antibiograms, the current gold standard in antibiotic susceptibility testing. The EPFL spin-off offers a diagnostic device, the rapid AST method, which is based on the detection of movement caused by living bacterial cells. The new method reduces the time taken to get a result from days to minutes, shows which specific antibiotic is effective against the bacteria, and significantly improves the chances of patients’ survival.
image source: HEMEX AG
19th November 2020
Antimicrobials: handle with care by HEMEX
The World Antimicrobial Awareness Week (WAAW) starts today, and this year’s slogan highlights the importance of encouraging best practices when it comes to using antimicrobials. Our portfolio company Resistell is helping to reduce the spreading of antibiotic resistance with their rapid Antimicrobial Susceptibility Testing.
16th November 2020
Resistell wins Special Life Science Award in Swiss Innovation Challenge 2020
Resistell, the start-up developing world’s fastest phenotypic antibiotic susceptibility test (rapid AST) won the Special Life Science Award in Swiss Innovation Challenge. The prestigious award is a great honour for Resistell and a huge confirmation for the whole team and the product itself.
3rd July 2020
Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC
Resistell AG, the start-up developing world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) programme in the latest funding round. Resistell’s project RAPID-SEP-AST will receive up to €2.5M grant and additional equity financing from EIC Fund.
19th June 2020
Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection
We invite you to study the "Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection" published in TrAC Trends in Analytical Chemistry, Volume 127, June 2020 by Jiri Dietvorst, Luïsa Vilaplana, Naroa Uria, Maria-Pilar Marco, Xavier Muñoz-Berbel.